+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Donepezil"

From
Alzheimer Disease Drugs Industry Forecasts - China Focus - Product Thumbnail Image

Alzheimer Disease Drugs Industry Forecasts - China Focus

  • Report
  • November 2023
  • 111 Pages
  • China
From
From
Alzheimer Disease Drugs Markets in China - Product Thumbnail Image

Alzheimer Disease Drugs Markets in China

  • Report
  • November 2023
  • 239 Pages
  • China
From
Alzheimer Disease - New Drugs, Markets and Companies - Product Thumbnail Image

Alzheimer Disease - New Drugs, Markets and Companies

  • Report
  • November 2021
  • 575 Pages
  • Global
From
From
Loading Indicator

Donepezil is a drug used to treat Alzheimer's Disease, a progressive neurological disorder that affects memory and cognitive function. It is a cholinesterase inhibitor, meaning it works by increasing the amount of the neurotransmitter acetylcholine in the brain. This helps to improve memory and cognitive function in people with Alzheimer's Disease. Donepezil is available in both oral and transdermal forms, and is usually taken once a day. It is generally well-tolerated, with the most common side effects being nausea, vomiting, and diarrhea. Donepezil is one of the most commonly prescribed drugs for Alzheimer's Disease, and is widely available in many countries. It is often used in combination with other drugs to treat the symptoms of Alzheimer's Disease. Companies in the Donepezil market include Pfizer, Eisai, Mylan, and Teva Pharmaceuticals. Show Less Read more